AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|
17 C
New York
Saturday, October 3, 2026

Tag: news

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of...

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Baidu Wenku Enables 20M AI-Generated PowerPoint Presentations Annually in China

2025 AI-Enhanced PowerPoint Tools Market Research Report: Baidu Wenku Tops 34M Monthly Visits, Doubles User Base BEIJING, July 29, 2025 /PRNewswire/ -- Baidu Wenku, launched by Baidu.Inc,...

Baidu Wenku Enables 20M AI-Generated PowerPoint Presentations Annually in China

2025 AI-Enhanced PowerPoint Tools Market Research Report: Baidu Wenku Tops 34M Monthly Visits, Doubles User Base BEIJING, July 29, 2025 /PRNewswire/ -- Baidu Wenku, launched by Baidu.Inc,...

Himax Subsidiary Liqxtal Proprietary Vision-Care Pro-Eye Monitor Named Finalist for Top Ten Age-Friendly Technology Product

Presented at Taiwan Healthy Ageing Tech Show in August Showcasing Senior Vision Care Innovation
Presented at Taiwan Healthy Ageing Tech Show in August Showcasing Senior Vision Care Innovation

Baidu Wenku Enables 20M AI-Generated PowerPoint Presentations Annually in China

2025 AI-Enhanced PowerPoint Tools Market Research Report: Baidu Wenku Tops 34M Monthly Visits, Doubles User Base BEIJING, July 29, 2025 /PRNewswire/ -- Baidu Wenku, launched by Baidu.Inc,...

Quest Global Signs Multi-Year Partnership with Andretti Formula E to Deliver Driving Performance and Innovation

WINDSOR, Conn. and LONDON, July 29, 2025 /PRNewswire/ -- Quest Global, a leading global product engineering services company, is proud to announce its multi-year...

MARE NOSTRUM : Chiffre d’affaires du 1er semestre 2025 de 56,7 ME – Nouvelle trajectoire de développement

MARE NOSTRUM
Chiffre d’affaires du 1er semestre 2025 de 56,7 M€
Nouvelle trajectoire de développement

Atari enters into an agreement to invest in Thunderful Group AB

Atari enters into an agreement to invest in Thunderful Group AB

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Progress on share buyback programme

Progress on share buyback programme

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews